Known targets — ChEMBL curated mechanism
PPARDPTGS1PTGS2dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Lysine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSR | P00390 | 2/20 | 0.91 |
| ▸ | ARG2 | P78540 | 4/20 | 0.59 |
| ▸ | ARG1 | P05089 | 3/20 | 0.55 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.54 |
| ▸ | NOS2 | P35228 | 4/20 | 0.52 |
| ▸ | NOS1 | P29475 | 3/20 | 0.52 |
| ▸ | BLM | P54132 | 1/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.48 |
| ▸ | NOS3 | P29474 | 2/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.48 |
| ▸ | GLA | P06280 | 1/20 | 0.48 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.48 |
| ▸ | APEX1 | P27695 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | GGT1 | P19440 | 2/20 | 0.48 |
| ▸ | GRM8 | O00222 | 1/20 | 0.48 |
| ▸ | GRM6 | O15303 | 1/20 | 0.48 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Lysine SCHEMBL9767765 | 1.00 | GSR (0.91) | GSRARG2ARG1RNPEPNOS2 | |
| Lysine SCHEMBL12470729 | 0.98 | GSR (0.87) | GSRARG2ARG1RNPEPNOS2 | |
| Lysine SCHEMBL706905 | 0.98 | GSR (0.95) | GSRARG2ARG1RNPEPNOS2 | |
| Lysine SCHEMBL41761 | 0.98 | GSR (0.95) | GSRARG2ARG1RNPEPNOS2 | |
| Lysine SCHEMBL41760 | 0.98 | GSR (0.95) | GSRARG2ARG1RNPEPNOS2 | |
| Lysine SCHEMBL1191963 | 0.98 | GSR (0.95) | GSRARG2ARG1RNPEPNOS2 | |
| Lysine SCHEMBL9762590 | 0.98 | GSR (0.95) | GSRARG2ARG1RNPEPNOS2 | |
| Lysine SCHEMBL1478318 | 0.98 | GSR (0.95) | GSRARG2ARG1RNPEPNOS2 | |
| Lysine SCHEMBL2478576 | 0.98 | GSR (0.95) | GSRARG2ARG1RNPEPNOS2 | |
| Lysine SCHEMBL10582149 | 0.98 | GSR (0.95) | GSRARG2ARG1RNPEPNOS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118986781-B | Composition for improving mitochondrial activity and application of composition in cosmetics | 山东福瑞达生物股份有限公司 | 2026-05-12 | — | — | CN | claimed |
| CN-118986781-A | Composition for improving mitochondrial activity and application of composition in cosmetics | 山东福瑞达生物股份有限公司 | 2024-11-22 | — | — | CN | claimed |
| CN-118986781-B | Composition for improving mitochondrial activity and application of composition in cosmetics | 山东福瑞达生物股份有限公司 | 2026-05-12 | — | — | CN | disclosed |
| EP-4635301-A2 | USE OF THE ASPARTIC ACID COPPER COMPLEX IN THE PREPARATION OF AN ANIMAL FEED ADDTIVE | Guangzhou Insighter Biotechnology Co., Ltd (CN) | 2025-10-22 | — | — | EP | disclosed |
| CN-119924416-A | Application of copper aspartate complex in preparation of animal feed additive | 广州英赛特生物技术有限公司 | 2025-05-06 | — | — | CN | disclosed |
| CN-118986781-A | Composition for improving mitochondrial activity and application of composition in cosmetics | 山东福瑞达生物股份有限公司 | 2024-11-22 | — | — | CN | disclosed |
| CN-118975950-A | Skin care composition for improving skin reddening and drying problems and application thereof | 山东福瑞达生物股份有限公司 | 2024-11-19 | — | — | CN | disclosed |
| US-20240366553-A1 | ASPARTIC ACID COPPER COMPLEX, AND USE THEREOF | Guangzhou Insighter Biotechnology Co., Ltd. (CN) | 2024-11-07 | — | — | US | disclosed |
| CN-118787576-A | Skin care composition with keratinization coating repairing effect and application thereof | 山东福瑞达生物股份有限公司 | 2024-10-18 | — | — | CN | disclosed |
| CN-118307691-A | Copper lysine hyaluronate chelate and application thereof | 山东省药学科学院 | 2024-07-09 | — | — | CN | disclosed |
| EP-4295698-A1 | ASPARTIC ACID COPPER COMPLEX, AND USE THEREOF | Guangzhou Insighter Biotechnology Co., Ltd (CN) | 2023-12-27 | — | — | EP | disclosed |
| WO-2022144044-A1 | ASPARTIC ACID COPPER COMPLEX, AND USE THEREOF | 源至技术有限公司 | 2022-07-07 | — | — | WO | disclosed |
| CN-113170837-A | Copper aspartate complex and application thereof | 彭险峰 | 2021-07-27 | — | — | CN | disclosed |
| US-5061815-A | Dietary supplementation | ZINPRO CORPORATION (US) | 1991-10-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240366553-A1 | ASPARTIC ACID COPPER COMPLEX, AND USE THEREOF | SOD1, ASNS, DDO | GSR 2180/4885ARG2 354/4885ARG1 178/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.